XML 59 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Oct. 01, 2022
Oct. 02, 2021
Oct. 01, 2022
Oct. 02, 2021
Jan. 01, 2022
Jan. 02, 2021
Summary of Significant Accounting Policies [Line Items]            
Financing Receivable, Sale $ 162,700 $ 106,600 $ 434,000 $ 319,800    
Financing Receivable, Significant Sales, Transaction Fees 1,200 300 2,300 800    
Basic:            
Net income $ 191,081 $ 146,812 $ 581,130 $ 495,160    
Shares (in shares) 160,587,000 162,166,000 161,205,000 162,707,000    
Per Share (in usd per share) $ 1.19 $ 0.91 $ 3.60 $ 3.04    
Effect of dilutive securities: [Abstract]            
Add: Option shares in the money and dilutive effect of non-vested stock (in shares) 3,755,000 5,403,000 3,837,000 5,512,000    
Less: Pro forma treasury shares (in shares) (707,000) (799,000) (715,000) (845,000)    
Diluted:            
Net Income $ 191,081 $ 146,812 $ 581,130 $ 495,160    
Shares (in shares) 163,635,000 166,770,000 164,327,000 167,374,000    
Per Share (in usd per share) $ 1.17 $ 0.88 $ 3.54 $ 2.96    
Antidilutive Securities [Abstract]            
Cash and cash equivalents $ 126,032   $ 126,032   $ 68,906  
Restricted cash 102   102   166  
Restricted cash included in other long-term assets 21,223   21,223   0  
Total cash, cash equivalents and restricted cash shown in the statement of cash flows $ 147,357 $ 67,360 $ 147,357 $ 67,360 $ 69,072 $ 81,720
Stock Options [Member]            
Antidilutive Securities [Abstract]            
Antidilutive securities excluded from computation of earnings per share (in shares) 0 0 0 0    
Non Vested Stock [Member]            
Antidilutive Securities [Abstract]            
Antidilutive securities excluded from computation of earnings per share (in shares) 223,157 187,484 249,618 216,622